ConductScience.org, home

Paper · 39609906

Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies.

Bakhshimoghaddam F and 11 others. BMC Nutr, 2024. Cited by 12 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies. Papers, record 39609906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39609906

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies.
PubMed
Journal
BMC Nutr
PubMed
Year
2024
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.77, provisional
iCite
Revised in PubMed
2025-05-30
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bakhshimoghaddam FFarnush
2Baez DDaniel
3Dolatkhah NNeda
4Sheikh MMahdi
5Poustchi HHossein
6Hekmatdoost AAzita
7Dawsey SStanford
8Kamangar FFarin
9Abnet CChristian
10Malekzadeh RReza

1 to 10 of 12Source PubMed

See all 12 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
001World Health OrganizationInternationalPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127,436,528Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease.Int J Food Sci Nutr2016https://conductscience.org/library/papers/27436528PubMed
221,392,646The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals.J Am Coll Cardiol2011https://conductscience.org/library/papers/21392646PubMed
332,706,078Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study.Eur Rev Med Pharmacol Sci2020https://conductscience.org/library/papers/32706078PubMed
431,162,803Association between nut consumption and non-alcoholic fatty liver disease in adults.Liver Int2019https://conductscience.org/library/papers/31162803PubMed
526,503,843The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.Liver Int2016https://conductscience.org/library/papers/26503843PubMed
630,700,946Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.World J Gastroenterol2019https://conductscience.org/library/papers/30700946PubMed
733,672,073Energy Expenditure Improved Risk Factors Associated with Renal Function Loss in NAFLD and MetS Patients.Nutrients2021https://conductscience.org/library/papers/33672073PubMed
830,674,308The association between adherence to the Mediterranean diet and hepatic steatosis: cross-sectional analysis of two independent studies, the UK Fenland Study and the Swiss CoLaus Study.BMC Med2019https://conductscience.org/library/papers/30674308PubMed
936,096,063The role of dietary factors in nonalcoholic fatty liver disease to hepatocellular carcinoma progression: A systematic review.Clin Nutr2022https://conductscience.org/library/papers/36096063PubMed
1033,234,342Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study.Clin Nutr2021https://conductscience.org/library/papers/33234342PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42,643,230Dietary patterns and their relationship with hepatobiliary health in patients with nonalcoholic fatty liver disease and gallstone disease.Front Nutr2026https://conductscience.org/library/papers/42643230PubMed
42,514,385
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Steatosis to Systemic Metabolic Failure: Classical Pathophysiology, Emerging Systemic Mechanisms and Modifiable Lifestyle Determinants.
Nutrients2026https://conductscience.org/library/papers/42514385PubMed
42,429,613Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42429613PubMed
42,088,286Mixture design-based optimization of bioactivities in steamed grain and legume blends.Food Chem X2026https://conductscience.org/library/papers/42088286PubMed
41,555,432Efficacy and safety of lower-carbohydrate dietary patterns for metabolic associated fatty liver disease: evidence from randomized controlled trials with grade analysis.Nutr Metab (Lond)2026https://conductscience.org/library/papers/41555432PubMed
40,244,373ASS1 is a hub gene and possible therapeutic target for regulating metabolic dysfunction-associated steatotic liver disease modulated by a carbohydrate-restricted diet.Mol Divers2025https://conductscience.org/library/papers/40244373PubMed
40,218,971Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD.Nutrients2025https://conductscience.org/library/papers/40218971PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39609906

GET https://conductscience.org/api/papers/v1/39609906/references?page=2